Answers are grounded in this paper and cite their sources.
Introduction There are conflicting data on whether former preterm birth is associated with QTc-Bazett prolongation in later life. Methods To explore QTc-Bazett interval differences between former preterm and/or extreme low birth weight (ELBW) cases and term-born controls in adolescence and young adulthood, we analyzed pooled individual data after a structured search on published cohorts. To test the absence of a QTc-Bazett difference, a non-inferiority approach was applied (one-sided, upper limit of the 95% CI mean QTc-Bazett difference, 5 and 10 ms). We also investigated the impact of characteristics on QTc-Bazett . Results The pooled dataset contained 164 preterms and/or ELBW (cases) and 140 controls from 3 studies. The median QTc-Bazett intervals were 409 (335–490) and 410 (318–480) ms in cases and controls. The mean QTc-Bazett difference was 1 ms, upper CI 95% of 6 ms (p=0.1015 and 0.0019 for 5 and 10 ms respectively). In the full dataset, females had a significantly longer QTc-Bazett than males (415 vs. 401 ms, p<0.0001), and there was a significant, but weak correlation (Spearman's 0.151, p=0.0377) between QTc-Bazett and plasma phosphate. Conclusions QTc-Bazett intervals are not significantly different between former preterm and/or ELBW cases and term-born controls, and we rejected a potential prolongation >10 ms in cases. When prescribing QTc prolonging drugs, pharmacovigilance practices in this subpopulation should be similar to the general public.
No takes yet. Share an insight, caveat, or question.
Vanthienen et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: